FDA approves RFID device to locate breast lumps

The Food and Drug Administration approved Faxitron’s device to identify breast lumps for removal prior to surgery.

Advertisement

Here are three things to know.

1. The Localizer is a wireless radiofrequency identification breast lesion localization system.

2. Clinicians can use the device to implant a mini RFID tag at the site of the breast lump up to 30 days prior to surgery.

3. The system includes a handheld mobile reader clinicians use to detect the tag within the breast.

More articles on supply chain:

Poll: GOP prioritizes lower drug prices over reducing government’s role in healthcare
10 most-read supply chain stories in Apri
Supply chain tip of the week: Target services — not supplies — for cost savings

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

  • Abbott has launched an updated version of its Oncodetect blood test, which helps clinicians determine whether cancer remains in patients…

  • Becker’s asked supply chain leaders: If you had an extra $1 million for your supply chain budget, where would it…

  • As hospitals redefine the role of supply chain leaders to focus on enterprise strategy, digital transformation and resilience, health systems…

Advertisement

Comments are closed.